Background Prostate cancer might have high radiation-fraction sensitivity that would give a
therapeutic advantage to hypofractionated treatment. We present a pre-planned analysis of …

Radiotherapy is one of the most important treatment options for localized early-stage or
advanced-stage prostate cancer (CaP). Radioresistance (relapse after radiotherapy) is a …

Background Using hypofractionation (fewer, larger doses of daily radiation) to treat localized
prostate cancer may improve convenience and resource use. For hypofractionation to be …

These guidelines cover a wide range of topics from prostate cancer epidemiology to
palliative care. Questions arising in daily clinical practice have been extracted and …

Background The role of androgen deprivation therapy (ADT) in combination with
radiotherapy (RT) in intermediate-risk prostate cancer (IRPC) remains controversial …

Purpose To compare biochemical outcome and toxicities of two prospective 5-fraction
stereotactic ablative radiotherapy (SABR) studies in prostate cancer. Materials and methods …

Although prostate cancer control using radiotherapy is dose‐dependent, dose–volume
effects on late toxicities in organs at risk, such as the rectum and bladder, have been …

Purpose Optimal prostate SABR dose-fractionation is unknown. This study compares long-
term outcomes from two prospective trials. Methods Study1 patients had low-risk PCa and …

Background Perirectal spacers may be beneficial to reduce rectal side effects from
radiotherapy (RT). Here, we present the impact of a hyaluronic acid (HA) perirectal spacer …

Purpose To investigate the feasibility of dose escalation and hypofractionation of pelvic
lymph node intensity modulated radiation therapy (PLN-IMRT) in prostate cancer (PCa) …